NO20081009L - Nye pyrido[3'2':4,5]furo[3,2-d]pyrimidinderivater - Google Patents
Nye pyrido[3'2':4,5]furo[3,2-d]pyrimidinderivaterInfo
- Publication number
- NO20081009L NO20081009L NO20081009A NO20081009A NO20081009L NO 20081009 L NO20081009 L NO 20081009L NO 20081009 A NO20081009 A NO 20081009A NO 20081009 A NO20081009 A NO 20081009A NO 20081009 L NO20081009 L NO 20081009L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- group
- groups
- alkoxy
- aryl
- Prior art date
Links
- JUQAECQBUNODQP-UHFFFAOYSA-N furo[3,2-d]pyrimidine Chemical class C1=NC=C2OC=CC2=N1 JUQAECQBUNODQP-UHFFFAOYSA-N 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- -1 amino, hydroxy Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- DCVNVQFCEXGISL-UHFFFAOYSA-N pyrido[4,5]furo[1,2-b]pyrimidine Chemical class N1=CN=C2C3=CC=CN=C3OC2=C1 DCVNVQFCEXGISL-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200501840A ES2281251B1 (es) | 2005-07-27 | 2005-07-27 | Nuevos derivados de pirido (3',2':4,5) furo (3,2-d) pirimidina. |
| PCT/EP2006/007218 WO2007017078A1 (en) | 2005-07-27 | 2006-07-21 | NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081009L true NO20081009L (no) | 2008-02-27 |
Family
ID=36121512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081009A NO20081009L (no) | 2005-07-27 | 2008-02-27 | Nye pyrido[3'2':4,5]furo[3,2-d]pyrimidinderivater |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20080221096A1 (es) |
| EP (1) | EP1913003A1 (es) |
| JP (1) | JP2009502832A (es) |
| KR (1) | KR20080039384A (es) |
| CN (1) | CN101263144A (es) |
| AR (1) | AR055999A1 (es) |
| AU (1) | AU2006278857A1 (es) |
| CA (1) | CA2616424A1 (es) |
| EC (1) | ECSP088108A (es) |
| ES (1) | ES2281251B1 (es) |
| IL (1) | IL188724A0 (es) |
| MX (1) | MX2008001034A (es) |
| NO (1) | NO20081009L (es) |
| PE (1) | PE20070237A1 (es) |
| RU (1) | RU2008107030A (es) |
| TW (1) | TW200738730A (es) |
| WO (1) | WO2007017078A1 (es) |
| ZA (1) | ZA200800352B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8318941B2 (en) | 2006-07-06 | 2012-11-27 | Bristol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| EP2226323A1 (en) * | 2009-02-27 | 2010-09-08 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
| CN102898432A (zh) * | 2011-07-29 | 2013-01-30 | 山东轩竹医药科技有限公司 | 三并环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| KR100774855B1 (ko) * | 2000-04-27 | 2007-11-08 | 아스텔라스세이야쿠 가부시키가이샤 | 축합 헤테로아릴 유도체 |
| WO2002088079A2 (en) * | 2001-05-01 | 2002-11-07 | Bristol-Myers Squibb Company | Dual inhibitors of pde 7 and pde 4 |
| ES2259892B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
| ES2259891B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
-
2005
- 2005-07-27 ES ES200501840A patent/ES2281251B1/es not_active Expired - Fee Related
-
2006
- 2006-07-21 MX MX2008001034A patent/MX2008001034A/es not_active Application Discontinuation
- 2006-07-21 CA CA002616424A patent/CA2616424A1/en not_active Abandoned
- 2006-07-21 EP EP06762762A patent/EP1913003A1/en not_active Withdrawn
- 2006-07-21 RU RU2008107030/04A patent/RU2008107030A/ru not_active Application Discontinuation
- 2006-07-21 AU AU2006278857A patent/AU2006278857A1/en not_active Abandoned
- 2006-07-21 JP JP2008523200A patent/JP2009502832A/ja active Pending
- 2006-07-21 WO PCT/EP2006/007218 patent/WO2007017078A1/en not_active Ceased
- 2006-07-21 US US11/996,781 patent/US20080221096A1/en not_active Abandoned
- 2006-07-21 KR KR1020087002113A patent/KR20080039384A/ko not_active Withdrawn
- 2006-07-21 CN CNA2006800338219A patent/CN101263144A/zh active Pending
- 2006-07-25 PE PE2006000897A patent/PE20070237A1/es not_active Application Discontinuation
- 2006-07-25 AR ARP060103191A patent/AR055999A1/es unknown
- 2006-07-27 TW TW095127490A patent/TW200738730A/zh unknown
-
2008
- 2008-01-10 IL IL188724A patent/IL188724A0/en unknown
- 2008-01-11 ZA ZA200800352A patent/ZA200800352B/xx unknown
- 2008-01-16 EC EC2008008108A patent/ECSP088108A/es unknown
- 2008-02-27 NO NO20081009A patent/NO20081009L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20080221096A1 (en) | 2008-09-11 |
| KR20080039384A (ko) | 2008-05-07 |
| MX2008001034A (es) | 2008-03-14 |
| ECSP088108A (es) | 2008-02-20 |
| ES2281251B1 (es) | 2008-08-16 |
| ZA200800352B (en) | 2008-12-31 |
| AR055999A1 (es) | 2007-09-12 |
| AU2006278857A1 (en) | 2007-02-15 |
| PE20070237A1 (es) | 2007-04-21 |
| CN101263144A (zh) | 2008-09-10 |
| RU2008107030A (ru) | 2009-09-10 |
| CA2616424A1 (en) | 2007-02-15 |
| TW200738730A (en) | 2007-10-16 |
| JP2009502832A (ja) | 2009-01-29 |
| WO2007017078A1 (en) | 2007-02-15 |
| IL188724A0 (en) | 2008-08-07 |
| ES2281251A1 (es) | 2007-09-16 |
| EP1913003A1 (en) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073283L (no) | Nye pyridotienopyrimidinderivater | |
| NO20080871L (no) | N-(Heteroaryl)-1-heteroarylalkyl-1 H-indol-2-karboksamidderivater, fremstilling og terapeutisk anvendelse derav | |
| AR078168A1 (es) | Derivados de piperidinas y piperazinas, procesos para prepararlos y sus usos como moduladores de gpr119 | |
| NO20092380L (no) | Amino-nikotin- og isonikotinsyrederivater anvendelige som DHODH-inhibitorer | |
| NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
| CA2939164A1 (en) | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use | |
| EA201100975A1 (ru) | Производные 1,2,4-оксадиазола и их применение в терапии | |
| NO20091012L (no) | Kinazolinon- og isokinolinonacetamid derivater | |
| NO20084832L (no) | Pyrimidinderivater som P13K-inhibitorer | |
| ES2895626T3 (es) | Derivados de imidazol condensados como inhibidores de TGF-beta | |
| TW200745118A (en) | Macrocylic inhibitors of hepatitis C virus | |
| TW200800949A (en) | Macrocylic inhibitors of hepatitis C virus | |
| PE20091039A1 (es) | IMIDAZO PIRAZINAS FUSIONADAS ARILO Y HETEROARILO [1,5-a] COMO INHIBIDORES DE LA FOSFODIESTERASA 10 | |
| AR053728A1 (es) | Pirimidinas condensadas como agonistas del receptor de acido nicotinico para el tratamiento de dislipidemia y composiciones farmaceuticas que las contienen en combinacion con otros agentes terapeuticos | |
| WO2009095792A3 (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
| NO20073729L (no) | Heterocykliske forbindelser som CCR2B-antagonister | |
| NO20073271L (no) | Nye pyridotienopyrimidinderivater | |
| NO975987L (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
| MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
| NO20073811L (no) | N-(heteroaryl)-1H-indol-2-karboksamidderivater og deres anvendelse som vanilloid TRPV1 reseptorligander | |
| CN106459046B (zh) | 作为激酶抑制剂的吡唑并吡啶衍生物 | |
| EA200971061A1 (ru) | Пиримидоновые соединения гетероариламидов | |
| MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
| NO20081009L (no) | Nye pyrido[3'2':4,5]furo[3,2-d]pyrimidinderivater | |
| MX2009012383A (es) | Derivados de arilamida pirimidona para el tratamiento de enfermedades neurodegenerativas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |